Pediatric Medicines Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global pediatric medicines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pediatric medicines is a branch of medicines that deals with the development, care for the management of diseases associated with infants, children, and adolescents. The major factor driving the growth of the market include the rising birth rate across the globe.
Moreover, the market is also
growing owing to new drug approvals. For instance, in June 2021, Novartis
announced the approval of Cosentyx (secukinumab) from the US Food and Drug
Administration (FDA). It is used for the treatment of moderate to severe plaque
psoriasis in pediatric patients six years and older who are candidates for
systemic therapy or phototherapy. Additionally, in September 2021, Amgen
announced the approval of Repatha (evolocumab) from the US Food and Drug
Administration (FDA). It is used as an adjunct to diet and other low-density
lipoprotein cholesterol (LDL-C)-lowering therapies to treat pediatric patients
aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH)
to reduce LDL-C.
To Request a Sample of our Report on Pediatric Medicines
Market: https://www.omrglobal.com/request-sample/pediatric-medicines-market
Some major players in the market include Gilead Sciences
Inc., Novartis International AG, and Johnson & Johnson Services, Inc.,
among others. The market players are contributing significantly to the growth
of the market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in October
2021, Enzyvant Therapeutics, Inc. announced that it has received approval for
Rethymic from the Food and Drug Administration (FDA) in the US. It is used to
treat pediatric patients with congenital athymia, a rare immune disorder.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
•
By Type
•
By Route of Administration
Regions Covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape- Gilead Sciences Inc., Novartis
International AG, and Johnson & Johnson Services, Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Pediatric Medicines Market is Available @ https://www.omrglobal.com/industry-reports/pediatric-medicines-market
Global Pediatric Medicines Market Report by Segment
By Type
• Respiratory
Disorder Drugs
• Autoimmune
Disorder Drugs
• Gastrointestinal
Drugs
• Cardiovascular
Drugs
• Others
By Route of Administration
• Oral
• Topical
• Parenteral
• Others
Global Pediatric Medicines Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment